Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Deals
Features
News
Region
Sectors
Size
Uncategorised

Series B

Instrumental orchestrates $20m
Stanford-StartX Fund has backed the electronics manufacturing management software developer, with the proceeds going to product development.
Thrive prospers with $257m round
Thrive Earlier Detection, the developer of an early cancer screening blood test invented at JHU, has raised $257m in series B funding.
Indigo Diabetes stabilises $44.5m
Indigo Diabetes increased its total funding to $52.6m with a series B round backed by Imec.xpand and returning investor Qbic.
Daily deal net: July 27, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Cerevance captures $65m series B
UPMC Enterprises has contributed to a $20m series B extension for Cerevance, which is commercialising Rockefeller University research.
Daily deal net: July 21, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Spin Memory executes extra series B cash
NYU-founded Spin Memory has now raised $60.3m in series B capital, having lured the return of Allied Minds, Arm and Applied Ventures.
Glympse Bio gleans series B funding
Section 32 has led a $46.7m series B round that will support further development of the MIT spinout's biosensor-based diagnostics device.

Other News

Daily deal net: July 14, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Paige pings investors for extra series B cash
Memorial Sloan Kettering spinout Paige’s series B total stands at $70m following a third tranche featuring Goldman Sachs and Healthcare Venture Partners.
Daily deal net: July 10, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
VarmX arms itself with $36.2m series B
Lundbeckfonden Ventures took a board seat at Leiden spinout VarmX as part of a round that will fund development of a treatment for spontaneous bleeding.
Vor leaps into $110m series B
Columbia University’s Vor Biopharma has collected more capital from shareholders including Osage University Partners, Johnson & Johnson and PureTech Health.
OxSonics sounds out $13.1m
The ultrasound therapeutics developer, a University of Oxford spinout, has raised series B2 funding in the run-up to clinical testing of its cancer drug delivery platform.

Editor's Picks

Big deal: Ribon ties together $65m series B
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Canvas paints $9m picture
Canvas Network, an online education platform developed by learning management software (LMS) provider Instructure which received $9.1m investment for the platform, has begun offering free and open online courses.
WRF finds its Resolve
In May 2010, Resolve raised $2m in the initial close of its A round before bringing in a corporate venturing unit later.
Imperial helps PsiOxus raise $34m
UK-listed investment fund Imperial Innovations joins GlaxoSmithKline's SR One, fund manager Invesco Perpetual and Lundbeckfond Ventures, backing the d cancer treatment company.
test reg

Login